The Manchester based technology firm has secured debt funding to boost cashflow ahead of major commercial deals.
"Securing this funding will play a key role in our expansion plans, providing us with the financial freedom to develop our tech platforms and target future partnerships. We have seen considerable interest for our ‘Digital Twin’ technology from across the manufacturing and engineering sectors, and with the ongoing support of both NPIF and GC Business Finance, we’re confident that we are in an excellent position to maximise our potential."
The private investment round was led by David Brownlow and Ben Rawson of Havisham Group.
"It was clear right from introducing David to our platform that he understood the value of what we’re creating, and matched our ambition to bring something entirely new to the market. Having someone of David’s calibre and experience will be invaluable as we expand into North America, and Asia Pacific this year."
The funding round was backed by Scottish Equity Partners and Columbia Lake Partners to support technology and team growth.
"Our ambition is as big as ever and this latest funding round absolutely signifies this. Our future focus remains on bringing simplicity, trust and transparency to our customers and the UK car finance market."
The round was led by BGF with participation from Parkwalk, Cambridge Enterprise, and Cambridge Innovation Capital.
"Parkwalk are delighted to continue to support the ground breaking technology from Dr Ken Smith’s laboratory at Addenbrookes, which enables the prognosis of IBD and an earlier clinical decision as to the correct drug treatment. This will significantly improve clinical outcomes and enhance patient welfare. The team at PredictImmune have done a magnificent job in productising the technology and are now taking the tests on their commercial pathway. We look forward to seeing the platform extended to benefit clinical outcomes in further diseases."
